Come up with a name for your new list and we'll add to it:
PharmaZell raised a round of funding on October 21, 2011. Investors include
Ergon Capital Partners.
PharmaZell develops and produces pharmaceutical active ingredients (API), provides services for formulation development and compiles required regulatory documents/dosiers for both the originator and g…